HUT72659A - Process for producing ring-substituted 2-amino-1,2,3,4-tetrahydro-naphthalenes and 3-amino-chromanes - Google Patents

Process for producing ring-substituted 2-amino-1,2,3,4-tetrahydro-naphthalenes and 3-amino-chromanes

Info

Publication number
HUT72659A
HUT72659A HU9500495A HU9500495A HUT72659A HU T72659 A HUT72659 A HU T72659A HU 9500495 A HU9500495 A HU 9500495A HU 9500495 A HU9500495 A HU 9500495A HU T72659 A HUT72659 A HU T72659A
Authority
HU
Hungary
Prior art keywords
amino
chromanes
naphthalenes
tetrahydro
substituted
Prior art date
Application number
HU9500495A
Other languages
English (en)
Other versions
HU225163B1 (en
HU9500495D0 (en
Inventor
Craig Steven Hoechstetter
Diane Lynn Huser
Johne Mehnert Schaus
Robert Daniel Titus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9500495D0 publication Critical patent/HU9500495D0/hu
Publication of HUT72659A publication Critical patent/HUT72659A/hu
Publication of HU225163B1 publication Critical patent/HU225163B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Lubricants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9500495A 1991-02-08 1992-02-07 Process for producing ring-substituted 2-amino-1,2,3,4-tetrahydro-naphthalenes and 3-amino-chromane intermediates HU225163B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65358391A 1991-02-08 1991-02-08
HU9200396A HU221184B1 (en) 1991-02-08 1992-02-07 Process for producing 8-izoxazolyl-2-amino-1,2,3,4-tetrahydronaphthalenes and 5-izoxazolyl-3-aminochromans and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
HU9500495D0 HU9500495D0 (en) 1995-04-28
HUT72659A true HUT72659A (en) 1996-05-28
HU225163B1 HU225163B1 (en) 2006-07-28

Family

ID=24621480

Family Applications (3)

Application Number Title Priority Date Filing Date
HU9500495A HU225163B1 (en) 1991-02-08 1992-02-07 Process for producing ring-substituted 2-amino-1,2,3,4-tetrahydro-naphthalenes and 3-amino-chromane intermediates
HU9200396A HU221184B1 (en) 1991-02-08 1992-02-07 Process for producing 8-izoxazolyl-2-amino-1,2,3,4-tetrahydronaphthalenes and 5-izoxazolyl-3-aminochromans and pharmaceutical compositions containing them
HU95P/P00389P HU211848A9 (en) 1991-02-08 1995-06-22 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU9200396A HU221184B1 (en) 1991-02-08 1992-02-07 Process for producing 8-izoxazolyl-2-amino-1,2,3,4-tetrahydronaphthalenes and 5-izoxazolyl-3-aminochromans and pharmaceutical compositions containing them
HU95P/P00389P HU211848A9 (en) 1991-02-08 1995-06-22 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes

Country Status (26)

Country Link
US (2) US5426226A (hu)
EP (2) EP0498590B1 (hu)
JP (1) JP3283892B2 (hu)
KR (1) KR100219995B1 (hu)
CN (2) CN1036392C (hu)
AT (2) ATE151419T1 (hu)
AU (2) AU653197B2 (hu)
BR (1) BR9200426A (hu)
CA (1) CA2060815C (hu)
CZ (1) CZ288067B6 (hu)
DE (2) DE69218813T2 (hu)
DK (2) DK0498590T3 (hu)
ES (2) ES2102456T3 (hu)
FI (1) FI920526A (hu)
GR (2) GR3023601T3 (hu)
HU (3) HU225163B1 (hu)
IE (1) IE920417A1 (hu)
IL (3) IL114760A (hu)
MX (1) MX9200505A (hu)
MY (1) MY116454A (hu)
NO (1) NO301825B1 (hu)
NZ (2) NZ241495A (hu)
PT (1) PT712837E (hu)
RU (2) RU2057751C1 (hu)
YU (1) YU48927B (hu)
ZA (1) ZA92767B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane
IL114760A (en) * 1991-02-08 1997-11-20 Lilly Co Eli Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
EP0697894A4 (en) * 1993-03-31 1996-05-01 Univ Pennsylvania DOPAMINE D-3 AND SEROTONIN (5-HT 1A) RECEPTOR LIGANDS AND IMAGING AGENTS
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
US6355674B1 (en) 1997-04-30 2002-03-12 Eli Lilly And Company Aminotetralins as 5-HT1D α Agonists
EP1052982A4 (en) * 1997-04-30 2004-10-06 Lilly Co Eli AMINOTETRALINS AS AGONISTS OF 5-HT 1D $ g (a)?
BR9810403A (pt) 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
KR20010079778A (ko) * 1998-09-09 2001-08-22 이시하라 겐조 제초제로 유용한 융합-벤젠 유도체
FR2792529B1 (fr) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
US6792563B1 (en) * 2000-04-28 2004-09-14 Intel Corporation Method and apparatus for bus activity tracking
CA2472763A1 (en) * 2002-02-13 2003-08-21 Pharmagene Laboratories Limited 5-ht2b receptor antagonists
SE0301798D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
CA1335106C (en) * 1989-02-27 1995-04-04 John Mehnert Schaus Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
FR2647365B1 (fr) * 1989-05-24 1991-08-30 Inst Francais Du Petrole Catalyseur multifonctionnel pour le traitement des gaz d'echappement des moteurs a combustion interne, contenant de l'uranium, au moins un promoteur de l'uranium et au moins un metal precieux et sa preparation
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
ES2123500T3 (es) * 1989-05-31 1999-01-16 Upjohn Co Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.
DE3919624A1 (de) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU631017B2 (en) * 1989-10-23 1992-11-12 Sumitomo Chemical Company, Limited 5-substituted-2,4-diphenylpyrimidine derivatives, their production and use
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
SE8904361D0 (sv) * 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane
IL114760A (en) * 1991-02-08 1997-11-20 Lilly Co Eli Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto

Also Published As

Publication number Publication date
CZ33292A3 (en) 1993-03-17
DE69231538T2 (de) 2001-06-07
ATE151419T1 (de) 1997-04-15
IE970857A1 (en) 2000-02-23
CN1140167A (zh) 1997-01-15
CN1036392C (zh) 1997-11-12
US5426226A (en) 1995-06-20
RU2057751C1 (ru) 1996-04-10
EP0712837A3 (en) 1997-05-21
ES2102456T3 (es) 1997-08-01
CA2060815A1 (en) 1992-08-09
IE920417A1 (en) 1992-08-12
FI920526A0 (fi) 1992-02-07
IL100858A0 (en) 1992-11-15
DE69231538D1 (de) 2000-11-30
FI920526A (fi) 1992-08-09
MY116454A (en) 2004-02-28
EP0498590B1 (en) 1997-04-09
DE69218813D1 (de) 1997-05-15
HU225163B1 (en) 2006-07-28
HU9500495D0 (en) 1995-04-28
MX9200505A (es) 1992-08-01
AU8168794A (en) 1995-02-23
HUT62569A (en) 1993-05-28
IL114760A0 (en) 1995-11-27
RU94044322A (ru) 1996-10-10
IL100858A (en) 1996-03-31
EP0712837A2 (en) 1996-05-22
YU12992A (sh) 1995-01-31
IL114760A (en) 1997-11-20
ATE197145T1 (de) 2000-11-15
DK0712837T3 (da) 2000-11-20
KR100219995B1 (ko) 1999-09-01
CA2060815C (en) 2002-05-14
AU664520B2 (en) 1995-11-16
NO920489D0 (no) 1992-02-06
AU1077592A (en) 1992-08-13
JP3283892B2 (ja) 2002-05-20
NO301825B1 (no) 1997-12-15
PT712837E (pt) 2001-03-30
GR3035190T3 (en) 2001-04-30
NZ264302A (en) 1995-04-27
GR3023601T3 (en) 1997-08-29
DE69218813T2 (de) 1997-08-14
NZ241495A (en) 1994-10-26
EP0712837B1 (en) 2000-10-25
CN1063870A (zh) 1992-08-26
HU9200396D0 (en) 1992-04-28
AU653197B2 (en) 1994-09-22
NO920489L (no) 1992-08-10
US5571942A (en) 1996-11-05
CN1052218C (zh) 2000-05-10
EP0498590A1 (en) 1992-08-12
YU48927B (sh) 2002-12-10
HU211848A9 (en) 1995-12-28
HU221184B1 (en) 2002-08-28
KR920016454A (ko) 1992-09-24
CZ288067B6 (cs) 2001-04-11
ZA92767B (en) 1993-08-03
BR9200426A (pt) 1992-10-13
DK0498590T3 (da) 1997-05-05
ES2153071T3 (es) 2001-02-16
JPH04327579A (ja) 1992-11-17
RU2105756C1 (ru) 1998-02-27

Similar Documents

Publication Publication Date Title
HUT72659A (en) Process for producing ring-substituted 2-amino-1,2,3,4-tetrahydro-naphthalenes and 3-amino-chromanes
PL309734A1 (en) Derivatives of 1-phenyl-3-dimethylaminopropane, method of obtaining them and anelgetic agent containing such derivatives
AU639053B2 (en) Immunosuppressant and process for preparing the same
HU9202199D0 (en) A new medical preparative containing benzomorphane
ZA931724B (en) New derivatives of beta-amino acids
YU111988A (en) Process for obtaining 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-/1/benzothieno/3,2-e/-1,2-thiazin-4-carboxamid-1,1-dioxide
GB9303334D0 (en) Chemical process
DE3587258T4 (de) Verfahren mit hoher Ausbeute zur Herstellung von Beta-Lactam-Antibiotika mit hoher Reinheit.
HUP9700103A2 (hu) 1,3,4-Tiadiazol-származékok és eljárás előállításukra
TW277059B (hu)
GB9115638D0 (en) Removal of chemical coatings from sand by combustion
DE58904420D1 (de) Verfahren zur herstellung von optisch aktiven acyloxyazetidinonen.
HUP9700105A2 (hu) 5-Fenil-1,3,4-tiadiazol-származékok, eljárás az előállításukra, és ilyen hatóanyagot tartalmazó gyógyászati készítmények
NZ333776A (en) Method for preparing alpha-chloroboronic acids from mannitol
MX9604540A (es) Derivados de aminoestilbazol y su farmaco.
HUT67697A (en) Process for the production of leather treating composition from environment-demaging protein sewage

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees